You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Proteasome Inhibition

Showing 1 - 25 of 3,069
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Proteasome Inhibition

Completed
  • Heart Failure
  • Multiple Myeloma
    • Philadelphia, Pennsylvania
    • +1 more
    Sep 10, 2020

    Cardiovascular Complications of Carfilzomib Treatment

    Active, not recruiting
    • Multiple Myeloma
      • Athens, Greece
        Department of Clinical Therapeutics, "Alexandra" General Hospita
      Apr 27, 2021

      Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

      Completed
      Has Results
      • Acute Leukemia
      • +4 more
      • Atlanta, Georgia
        Northside Hospital
      Sep 1, 2021

      Autoimmune Hepatitis Trial in Indianapolis (zetomipzomib, )

      Recruiting
      • Autoimmune Hepatitis
      • Indianapolis, Indiana
        Indiana University
      Jan 13, 2023

      Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

      Active, not recruiting
      • Multiple Myeloma
      • Auto Stem Cell Transplant
      • Hackensack, New Jersey
        John Theurer Cancer Center @ Hackensack University Medical Cente
      Dec 23, 2022

      Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

      Terminated
      • Multiple Myeloma
      • Milano, Italy
      • +10 more
      Jul 4, 2022

      Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a

      Recruiting
      • Autoimmune Hemolytic Anemia
      • Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
      • combination of a single dose anti-CD20 antibody and bortezomib
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Oct 12, 2021

      Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)

      Active, not recruiting
      • Glioblastoma Multiforme
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 22, 2022

      Lupus Nephritis, Systemic Lupus Erythematosus Trial in Worldwide (KZR-616)

      Active, not recruiting
      • Lupus Nephritis
      • Systemic Lupus Erythematosus
      • Los Angeles, California
      • +49 more
      Mar 10, 2022

      Multiple Myeloma Trial in Washington, Hackensack (Melphalan, Bortezomib)

      Active, not recruiting
      • Multiple Myeloma
      • Washington, District of Columbia
      • +1 more
      May 6, 2022

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

      Recruiting
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • Des Moines, Iowa
      • +8 more
      Jan 12, 2023

      Follicular Lymphoma Trial in Chicago (Bortezomib and Tositumomab I-131)

      Terminated
      Has Results
      • Follicular Lymphoma
      • Bortezomib and Tositumomab I-131
      • Chicago, Illinois
        Rush University Medical Center
      Oct 6, 2021

      Breast Tumor Female, Metastatic Breast Cancer Trial in Olomouc (Disulfiram)

      Recruiting
      • Breast Neoplasm Female
      • Metastatic Breast Cancer
      • Olomouc, Czechia
        University Hospital Olomouc
      Aug 2, 2022

      Sensitisation, Highly Sensitised Dialysis Patients Trial in La Tronche (Each patient will undergo in the first step of the study

      Recruiting
      • Sensitisation
      • Highly Sensitised Dialysis Patients
      • Each patient will undergo in the first step of the study belatacept treatment and in the second apheresis and daratumumab
      • La Tronche, France
        Chu Grenoble
      May 12, 2022

      Relapsed Solid Tumors, Refractory Solid Tumors, Relapsed Leukemia Trial in Canada, United States (Carfilzomib, Cyclophosphamide,

      Recruiting
      • Relapsed Solid Tumors
      • +3 more
      • Phoenix, Arizona
      • +7 more
      Apr 12, 2022

      Autoinflammatory Diseases

      Recruiting
      • NOMID
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 14, 2023

        Glioblastoma, Malignant Glioma Trial in Canada, Switzerland, United States (drug, radiation, device)

        Completed
        • Glioblastoma
        • Malignant Glioma
        • La Jolla, California
        • +7 more
        Apr 13, 2021

        Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

        Active, not recruiting
        • Multiple Myeloma
        • High-Risk Cancer
        • Bortezomib following nonmyeloablative allogeneic transplant
        • Montreal, Quebec, Canada
          Hôpital Maisonneuve-Rosemont
        Aug 22, 2022

        Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Bortezomib, Carfilzomib)

        Completed
        Has Results
        • Relapsed and/or Refractory Multiple Myeloma
        • Kamogawa, Chiba, Japan
        • +22 more
        Jul 27, 2022

        Waldenstrom Macroglobulinemia Trial in Hackensack (Carfilzomib, Rituximab, Dexamethasone)

        Completed
        Has Results
        • Waldenstrom Macroglobulinemia
        • Hackensack, New Jersey
          John Theurer Cancer Center at Hackensack University Medical Cent
        Mar 18, 2022

        CD20 Positive, Recurrent DLBCL, Refractory DLBCL Trial in Buffalo (drug, other, biological)

        Active, not recruiting
        Has Results
        • CD20 Positive
        • +6 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        Oct 11, 2021

        Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)

        Completed
        Has Results
        • Multiple Myeloma
        • Thalidomide+Melphalan +Bortezomib+stem cell transplant
        • Hackensack, New Jersey
          John Theurer Cancer Center at Hackensack University Medical Cent
        Dec 16, 2022

        Mantle-Cell Lymphoma Trial in United States (Ixazomib, Ibrutinib)

        Active, not recruiting
        • Mantle-Cell Lymphoma
        • Atlanta, Georgia
        • +13 more
        Nov 17, 2022

        Glioblastoma Trial in Saint Louis (Temozolomide, Disulfiram, Copper gluconate)

        Completed
        • Glioblastoma
        • Saint Louis, Missouri
          Washington University School of Medicine
        Jul 19, 2018

        Multiple Myeloma Trial in Hackensack (Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone)

        Active, not recruiting
        • Multiple Myeloma
        • Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone
        • Hackensack, New Jersey
          Hackensack University Medical Center
        Oct 4, 2021